• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB mediated down-regulation of claudin-5

Bradykinin increased the permeability of BTB via NOS/NO/ZONAB mediated down-regulation of claudin-5

来源 :The 6th FAONS Congress and 11th Biennial Conference of CNS(第 | 被引量 : 0次 | 上传用户：shylockbc
【摘 要】
：
We have demonstrated that bradykinin(BK)could increase the permeability of blood-tumor barrier(BTB)via down-regulating the protein expressions of tight junction(TJ)associated protein claudin-5 and occ
【作 者】
：
Li-Bo Liu Xiao-Bai Liu Jun Ma Yun-Hui Liu Zhi-Qing Li Teng Ma Xi-He Zhao Zhuo Xi Yi-Xue Xue 
【机 构】
：
Department of Neurobiology,College of Basic Medicine,China Medical University,Shenyang,P.R.China,110
【出 处】
：
The 6th FAONS Congress and 11th Biennial Conference of CNS(第
【发表日期】
：
2015年3期
【关键词】
：
Bradykinin Blood-tumor barrier NOS ZONAB Apg-2 tight junction 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　We have demonstrated that bradykinin(BK)could increase the permeability of blood-tumor barrier(BTB)via down-regulating the protein expressions of tight junction(TJ)associated protein claudin-5 and occludin in previous study,but the possible mechanism is unclear.
其他文献
The study of circulating biomarker panels in early diagnosis of Alzheimer's disease
Early,reliable and non-invasive diagnosis of Alzheimer disease(AD)is a great challenge,which makes the prognosis and therapeutic interventions quite difficult.
会议
Alzheimer’s diseasemicroRNAbiomarker panel
A potential target for the treatment of Parkinson's disease:Effect of lateral habenula lesions
Parkinsons disease(PD)is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway.
会议
Parkinson's diseaseLHbDopamineSubstantia nigra pars compactaStriatum
Sodium butyrate ameliorates memory deficit,increases neurogenesis and reduces inflammation in presen
会议
Presenilin1 mutants alter the cleavage pathway of longer forms of Amyloidβ protein
Objective Alzheimer disease is characterized by progressive memory loss and damaging of cognitive functions.
会议
Familial Alzheimer’s diseaseγ-secretasesPresenilin1Amyloid β-peptide
Etidronate and trisphosphonates are new potential candidates for neuroprotective drugs for Alzheimer
Objective Bisphosphonates(BP)is a category of drugs that are used to treat various bone diseases,such as osteoporosis,Pagets disease,bone malignancy and other skeletal complications involving excessiv
会议
EtidronateTrisphosphonatesAlzheimer'sPC12 cellsGlutamateNeuroprotectio
Alteration of dopamine related oxidase in stomach and duodenum of 6-hydroxydopamine-induced Parkinso
Parkinsons disease(PD)is characterized by degeneration of dopaminergic neurons in the substantia nigra.Besides,the changes of dopaminergic neurons have been reported in enteric nervous system of PD pa
会议
Parkinson’s diseaseGastrointestinalTyrosine hydroxylase (TH)Catechol-O-methyl
Ethnic differences in OPRK1 promoter methylation in Xinjiang Uygur and Han populations,China
Background: Mild cognitive impairment(MCI)is an intermediate period between normal ageing and Alzheimer disease.
会议
mild cognitive impairmentmethylationOPRK1HanUygur
Protection effect of piperine and piperlonguminine from Piper longum L.alkaloids against rotenone-in
Objective Parkinson disease(PD)is a chronic progressive disease which could involve multiple systems at its early stage while the central nervous system was finally injured at its later stage and mani
会议
Parkinson’s diseasetreatmentmitochondrial permeability transition pore
Changes of dendritic spines and synapses in the process of brain development in APP/PS1 mice
Objective Alzheimers disease(AD)is the most common form of dementia in elderly people.
会议
Alzheimer’s diseasedendritic spinedevelopmentAβhippocampus
Involvement of ephrinB/EphB1 forward signaling in retinal Müller cell gliosis
Objective Müller cell gliosis is a common response in virtually all forms of retinal diseases including glaucoma.
会议
EphB1 receptorMuller cell gliosisGFAPephrineB/EphB forward signaling